4//SEC Filing
ARIAD PHARMACEUTICALS INC 4
Accession 0000884731-16-000109
CIK 0000884731operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:17 PM ET
Size
307.5 KB
Accession
0000884731-16-000109
Insider Transaction Report
Form 4
Bollag Daniel M
Sr. VP, Reg. Affairs & Quality
Transactions
- Sale
Common Stock
2016-10-03$13.46/sh−47,384$637,812→ 129,404 total
Footnotes (2)
- [F1]Shares were sold pursuant to a Rule 10b5-1 trading plan dated June 15, 2016
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.33 to $13.65 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer,or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
Issuer
ARIAD PHARMACEUTICALS INC
CIK 0000884731
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000884731
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:17 PM ET
- Size
- 307.5 KB